Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius : Buys Colombia's CediMed in EUR40 Million Investment

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/04/2019 | 04:33am EST

By Carlo Martuscelli

Fresenius SE & Co. KGaA (FRE.XE) said Monday that it has acquired CediMed, a Colombian diagnostics group, in an investment totaling about 40 million euros ($44.7 million).

The deal was executed through Quironsalud, Fresenius's Spanish private hospital group, and is aimed at strengthening the company's presence in Latin America's health-care services market.

Fresenius said it expects to close the deal in the next few months.

Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com; @carlomartu

Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.95% 65.96 Delayed Quote.15.36%
FRESENIUS SE & CO. KGAA 0.97% 50.81 Delayed Quote.18.74%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS SE & CO. KGAA
12/09FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of quarter..
EQ
12/09FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of financi..
EQ
11/30FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
11/15Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations..
AQ
11/11FRES &C : Fresenius Kabi AG - Omega-3 fatty-acid enriched parenteral nutrition i..
AQ
11/06International companies to host live webcasts at Deutsche Bank's Depositary R..
AQ
11/05FRESENIUS : Vamed wins awards for spa and wellness facilities
PU
11/04FRESENIUS : Helios acquires medical diagnostics provider in Colombia
PU
11/04FRESENIUS : Buys Colombia's CediMed in EUR40 Million Investment
DJ
11/01FRESENIUS : Medical Care North America achieves strongest quality ratings to dat..
PU
More news
Financials (EUR)
Sales 2019 35 347 M
EBIT 2019 4 588 M
Net income 2019 1 814 M
Debt 2019 18 684 M
Yield 2019 1,60%
P/E ratio 2019 15,2x
P/E ratio 2020 14,1x
EV / Sales2019 1,33x
EV / Sales2020 1,22x
Capitalization 28 315 M
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 55,42  €
Last Close Price 50,81  €
Spread / Highest target 47,2%
Spread / Average Target 9,07%
Spread / Lowest Target -36,1%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors